Polar Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-315,000
| Closed | -$11.4M | – | 266 |
|
|
2016
Q4 | $11.4M | Buy |
315,000
+25,000
| +9% | +$906K | 0.18% | 141 |
|
|
2016
Q3 | $13.3M | Buy |
290,000
+72,433
| +33% | +$3.33M | 0.23% | 123 |
|
|
2016
Q2 | $10.9M | Sell |
217,567
-645,000
| -75% | -$32.4M | 0.21% | 129 |
|
|
2016
Q1 | $46.2M | Buy |
862,567
+125,967
| +17% | +$6.74M | 0.87% | 36 |
|
|
2015
Q4 | $48.3M | Buy |
736,600
+521,600
| +243% | +$34.2M | 0.87% | 35 |
|
|
2015
Q3 | $12.1M | Buy |
215,000
+24,000
| +13% | +$1.35M | 0.25% | 126 |
|
|
2015
Q2 | $11.3M | Sell |
191,000
-329,000
| -63% | -$19.4M | 0.22% | 136 |
|
|
2015
Q1 | $32.4M | Sell |
520,000
-230,000
| -31% | -$14.3M | 0.61% | 52 |
|
|
2014
Q4 | $43.1M | Buy |
750,000
+389,787
| +108% | +$22.4M | 0.84% | 33 |
|
|
2014
Q3 | $19.4M | Sell |
360,213
-64,787
| -15% | -$3.48M | 0.41% | 79 |
|
|
2014
Q2 | $22.3M | Buy |
+425,000
| New | +$22.3M | 0.47% | 70 |
|
|
2013
Q4 | – | Sell |
-100,000
| Closed | -$3.78K | – | 282 |
|
|
2013
Q3 | $3.78K | Hold |
100,000
| – | – | 0.1% | 200 |
|
|
2013
Q2 | $3.92M | Buy |
+100,000
| New | +$3.92M | 0.14% | 189 |
|